SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Fresenius Kabi wants Wockhardt to amend Zosyn approval BSE filing

Fresenius Kabi wants Wockhardt to change a BSE filing it says does not accurately reflect its role in the production of a Zosyn generic recently approved in the US.

Mylan confirms plan to close Meda Soma plant in Illinois

Mylan will close a manufacturing site in Decatur, Illinois that it gained when it bought Swedish drug maker Meda last year.

Wockhardt says US FDA has approved Fresenius Kabi-made generic Zosyn

Wockhardt claims the US has approved its version of the combination antibiotic Zosyn (piperacillin and tazobactam).

Half of CMOs unprepared for serialisation requirements, says Tracelink

As many as 400 contract manufacturing organisations (CMOs) will not be ready for upcoming US and EU track-and-trace regulations, says supply chain services firm TraceLink.

News in brief

Permira to buy Lyophilization Services of New England

Private equity fund Permira has announced its intention to buy freeze drying firm Lyophilization Services of New England Inc (LSNE) 

Lilly: Tax reforms would release $150m to further support US manufacturing

Eli Lilly will invest $850m in its US operations this year but warns the country’s antiquated tax system leaves the firm at a competitive disadvantage.

EMA looks to suspend 331 drugs due to ‘misrepresentation of study data’ at Indian CRO

Sandoz and Aurobindo are among drugmakers which will need to provide alternative bioequivalence data after the EMA recommended suspension of medicines tested by Micro Therapeutic Research Labs.

Alexion licenses mRNA delivery tech from Arbutus in potential $82.5m deal

Alexion Pharmaceuticals will use the LNP delivery licensed from Arbutus Biopharma as part of its messenger RNA therapeutics development partnership with Moderna Therapeutics.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...